Reseachers identify first blood biomarker for myocarditis Hina Zahid28 May 2021 9:53 AM ISTSpain: The human homolog of micro RNA miR-721 could be used for distinguishing patients with myocarditis from those with myocardial infarction,...
Systolic BP lowering to less than 120 mm Hg aggressively reduces mortality: NEJM Medha Baranwal22 May 2021 10:30 AM ISTUSA: Lowering of systolic blood pressure (SBP) to less than 120 mm Hg reduces the rate of MACE and all-cause mortality compared to lowering SBP to...
Tympanostomy tubes don't offer long lasting benefit over antibiotics for ear infections in children: Study Medha Baranwal13 May 2021 9:45 AM ISTUSA: Tympanostomy-tube placement compared to medical management did not significantly lower the rate of acute otitis media during a 2-year period in...
Four-month rifapentine regimen for TB equally effective as 6-month standard regimen: NEJM Medha Baranwal6 May 2021 6:45 AM ISTUSA: The effectiveness of a 4-month rifapentine-based regimen containing moxifloxacin is noninferior to the standard 6-month regimen for the treatment...
Dexmedetomidine, Propofol give similar outcomes in septic ventilated patients: MENDS2 trial Medha Baranwal29 April 2021 11:59 PM ISTUSA: The administration of dexmedetomidine or propofol yields similar outcomes in mechanically ventilated adults with sepsis being treated with light...
Bimekizumab scores over adalimumab in achieving plaque psoriasis clearance: NEJM Medha Baranwal28 April 2021 10:50 AM ISTUK: Bimekizumab was shown to be noninferior and superior to adalimumab in reducing signs and symptoms of plaque psoriasis in a 56-week trial. However,...
Tranexamic acid plus uterotonic agents significantly reduce postpartum blood loss: NEJM Medha Baranwal27 April 2021 8:15 AM ISTUSA: Tranexamic acid treatment in women who underwent cesarean delivery and received uterotonic agents significantly reduced blood loss greater than...
Abrocitinib significantly improves moderate-to-severe atopic dermatitis;NEJM Dr Satabdi Saha19 April 2021 7:45 AM ISTAbrocitinib at a dose of either 200 mg or 100 mg once daily resulted in significantly greater reductions in signs and symptoms of moderate-to-severe...
Magic mushroom compound performs as well as escitalopram in depression: NEJM Medha Baranwal15 April 2021 10:45 AM ISTUK: Researchers in a recent study found no significant difference in antidepressant effects between psilocybin and escitalopram. According to the...
Lower oxygenation target does not reduce mortality in acute hypoxemic respiratory failure: NEJM Medha Baranwal8 April 2021 7:10 PM ISTDenmark: A lower oxygenation target in patients with acute hypoxemic respiratory failure in the ICU did not result in lower mortality versus higher...
Sutimlimab increases Hb levels, prevents hemolysis in cold agglutinin disease: NEJM Medha Baranwal8 April 2021 7:45 AM ISTDelhi: Selective upstream inhibition of activity in the classic complement pathway rapidly reduced fatigue, increased hemoglobin levels, and halted...
Lumasiran reduces kidney failure risk in primary hyperoxaluria type 1 patients: NEJM Medha Baranwal3 April 2021 11:15 AM ISTDelhi: The administration of lumasiran reduces the excretion of urinary oxalate -- the cause of progressive kidney failure in patients with primary...
